Renaissance Technologies LLC Reduces Holdings in Retractable Technologies, Inc. (NYSE:RVP)

Renaissance Technologies LLC reduced its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 5.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 340,759 shares of the company’s stock after selling 18,134 shares during the quarter. Renaissance Technologies LLC owned approximately 1.14% of Retractable Technologies worth $368,000 as of its most recent filing with the Securities and Exchange Commission.

Retractable Technologies Price Performance

Retractable Technologies stock opened at $0.76 on Friday. Retractable Technologies, Inc. has a 12-month low of $0.71 and a 12-month high of $1.34. The stock has a market capitalization of $22.72 million, a P/E ratio of -1.24 and a beta of 2.06. The firm’s 50-day moving average is $0.90 and its two-hundred day moving average is $1.03. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million for the quarter.

Insiders Place Their Bets

In other news, CEO Thomas J. Shaw purchased 71,422 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were bought at an average cost of $0.82 per share, with a total value of $58,566.04. Following the purchase, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have bought 182,128 shares of company stock valued at $166,565 in the last ninety days. Insiders own 55.00% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a report on Thursday. They set a “hold” rating for the company.

Retractable Technologies Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.